Etanercept and methotrexate combination therapy

Clinical and Experimental Rheumatology

Volumn 17, Issue 6 SUPPL. 18, 1999, Pages

  Bankhurst, A D ^a,b  

^a Molecular Genetics and Microbiology   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Combination therapy; Etanercept; Methotrexate; Rheumatoid arthritis; Tumor necrosis factor

Indexed keywords

ETANERCEPT; FC RECEPTOR; HYBRID PROTEIN; METHOTREXATE; PLACEBO; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; ISOXAZOLES; MALE; METHOTREXATE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0032693261     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. FIRESTEIN GS, ZVAIFLER NJ: How important are cells in chronic rheumatoid arthritis? Arthritis Rheum 1990; 33: 768-73.
2. SEWELL KL, TRENTHAM DE: Pathogenesis of rheumatoid arthritis. Lancet 1993; 341: 283.
3. FELDMANN M, BRENNAN FM, MAINI RN: Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 1: 397-440.
4. ELLIOTT MJ, MAINI RN, FELDMANN M, et al: Randomized double blind comparison of chimeric antibody to tumor necrosis factor-α (cA2) versus placebo in rheumatoid arthritis. Lancet 1994; 344: 1105-10.
5. ELLIOTT MJ, MAINI RN, FELDMANN M, et al.: Repeated therapy with monoclonal antibody to tumor necrosis factor-α (cA2) in patients with rheumatoid arthritis. Lancet 1994; 344: 1125-7.
6. MORELAND LW, BAUMGARTNER SW, SCHIFF MH, et al.: Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997; 33: 141-147.
7. MORELAND LW, SCHIFF MH, BAUMGARTNER SW, et al.: Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med 1999; 130: 478-86.
8. PINCUS T, MARCUM SB, CALLAHAN LF: Long-term drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second-line drugs and prednisone. J Rheumatol 1992; 19: 1885-94.
9. THE NORTH AMERICAN RHEUMATOID ARTHRITIS DISEASE MANAGEMENT STUDY GROUP: Selection of DMARD therapy in rheumatoid arthritis (abstract). Arthritis Rheum 1998; 41 (Suppl. 9): S269.
10. TUGWELL P, BENNETT K, GENT M: Methotrexate in rheumatoid arthritis. Indications, contraindications, efficacy and safety. Ann Intern Med 1987; 107: 358-66.
11. ALARCON GS, TRACY IC, STRAND GM, SINGH K, MACALASO M: Survival and drug discontinuation analyses in a large cohort of methotrexate treated rheumatoid arthritis patients. Ann Rheum Dis 1995; 54: 708-12.
12. WEINBLATT ME, KREMER JM, BANKHURST AD, et al.: A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Eng J Med 1999; 340: 253-9.
13. ARNETT FC, EDWORTHY SM, BLOCH DA, et al.: the American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
14. HOCHBERG MC, CHANG RW, DWOSH I, et al.: American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 1992; 35: 498-502.
15. WOLFE F, HAWLEY DJ, CATHEY MA: Termination of slow-acting antirheumatic therapy in rheumatoid arthritis: A 14-year prospective evaluation of 1017 consecutive starts. J Rheumatol 1990; 17: 994-1001.
16. WEINBLATT ME, WEISSMAN BN, HOLDSWORTH DE, et al.: Long term prospective study of methotrexate in the treatment of rheumatoid arthritis: 84 month update. Arthritis Rheum 1992; 35: 129-38.
17. PINCUST, STEIN CM, WOLFE F: "No evidence of disease" in rheumatoid arthritis using methotrexate in combination with other drugs: A contemporary goal for rheumatology care? Clin Exp Rheumatol 1997; 15: 591-6.
18. FELSON DJ, ANDERSON JS, MACNAN RF: The efficacy and toxicity of combination therapy in rheumatoid arthritis: A meta analysis. Arthritis Rheum 1994; 37: 1487-93.
19. O'DELL JR, HAIRE CE, ERIKSON N, et al.: Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 1996; 334: 1287-91.
20. TUGWELL P, PINCUS T, YOCUM D, et al: Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med 1995; 333: 137-141.
21. MORELAND LW, BAUMGARTNER SW, TINDALL EA, et al.: Long term treatment of DMARD failing rheumatoid arthritis with TNF receptor P75 Fc fusion protein (TNFR:Fc, Enbrel). J Invest Med 1998; 46: 229A (abstr.).